Clinical trial
Zmax Compared to Augmentin in Sinusitis
NCT00367120 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00367120 |
|---|---|
| Title | Zmax Compared to Augmentin in Sinusitis |
| Official title | A Multicenter, Randomized, Open Label Comparative Study Of Azithromycin Extended Release (ZMAX) Versus Amoxicillin/Clavulanate Potassium In Subjects With Acute Bacterial Sinusitis (ABS) In A Physician Practice Environment |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sinusitis |
| Intervention type | Drug |
| Interventions | Azithromycin Extended Release, Amoxicillin/Clavulanate |
| Enrollment | 762 |
| Start date | Jun 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Aug 22, 2006 |
| Last update posted | Mar 16, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: